Cargando…

Minimally invasive perventricular device closure of doubly committed sub-arterial ventricular septal defects: single center long-term follow-up results

BACKGROUND: To evaluate the long-term safety and efficacy of using perventricular device closure in treating selected patient with doubly committed sub-arterial ventricular septal defect (VSD) METHODS: During July 2007 and April 2011, 86 patients with doubly committed subarterial VSD who met the inc...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Shu, Zhu, Da, An, Qi, Tang, Hong, Li, Dajiang, Lin, Ke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4572622/
https://www.ncbi.nlm.nih.gov/pubmed/26374555
http://dx.doi.org/10.1186/s13019-015-0326-6
_version_ 1782390417187143680
author Zhang, Shu
Zhu, Da
An, Qi
Tang, Hong
Li, Dajiang
Lin, Ke
author_facet Zhang, Shu
Zhu, Da
An, Qi
Tang, Hong
Li, Dajiang
Lin, Ke
author_sort Zhang, Shu
collection PubMed
description BACKGROUND: To evaluate the long-term safety and efficacy of using perventricular device closure in treating selected patient with doubly committed sub-arterial ventricular septal defect (VSD) METHODS: During July 2007 and April 2011, 86 patients with doubly committed subarterial VSD who met the inclusion criteria were enrolled in this study. Perventricular closure was attempted using a unique design eccentric device under the guidance of transesophageal echocardiography. Complications such as residual shunt, arrhythmia, valve regurgitation were all recorded in postoperative period and during follow-up. Multiple logistic regression analysis was performed to study risk factors for procedure failure and complications. RESULT: Perventricular device closure was successfully done in 75 patients (87.2 %) with mean age 7.0 ± 7.0 years old, VSD size 4.8 ± 1.5 mm and device size 6.7 ± 1.7 mm. Complete closure rate was achieved in 94.7 % at discharge and 96 % during follow-up. No severe complications such as device embolism, significant arrhythmia, left ventricular outflow tract obstruction as well as obvious valve regurgitation were noted during follow-up (Mean 4.5 ± 1.5 years). Procedure induced trivial-mild grade aortic valve regurgitation (AR) was noted in 16 (21.3 %) patients at discharge while 8 of them resolved during follow-up. Multivariable analysis revealed that procedure-induced AR was associated device diameter to patients’ weight (OR = 12.3 95 % CI 1.5- 99.2). Perventricular device closure was failed in 11 patients, preoperative aortic valve prolapse was the major risk factor for failure of the procedure (OR = 65 95 % CI 7.5- 564.1). CONCLUSION: Perventricular closure of doubly committed subarterial VSDs appears to be a safe and effective minimally invasive treatment option in selected patients with good long-term outcomes. CLINICAL TRIAL REGISTRATION: Unique Identifier: ChiCTR-TNC-00000203.
format Online
Article
Text
id pubmed-4572622
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-45726222015-09-18 Minimally invasive perventricular device closure of doubly committed sub-arterial ventricular septal defects: single center long-term follow-up results Zhang, Shu Zhu, Da An, Qi Tang, Hong Li, Dajiang Lin, Ke J Cardiothorac Surg Research Article BACKGROUND: To evaluate the long-term safety and efficacy of using perventricular device closure in treating selected patient with doubly committed sub-arterial ventricular septal defect (VSD) METHODS: During July 2007 and April 2011, 86 patients with doubly committed subarterial VSD who met the inclusion criteria were enrolled in this study. Perventricular closure was attempted using a unique design eccentric device under the guidance of transesophageal echocardiography. Complications such as residual shunt, arrhythmia, valve regurgitation were all recorded in postoperative period and during follow-up. Multiple logistic regression analysis was performed to study risk factors for procedure failure and complications. RESULT: Perventricular device closure was successfully done in 75 patients (87.2 %) with mean age 7.0 ± 7.0 years old, VSD size 4.8 ± 1.5 mm and device size 6.7 ± 1.7 mm. Complete closure rate was achieved in 94.7 % at discharge and 96 % during follow-up. No severe complications such as device embolism, significant arrhythmia, left ventricular outflow tract obstruction as well as obvious valve regurgitation were noted during follow-up (Mean 4.5 ± 1.5 years). Procedure induced trivial-mild grade aortic valve regurgitation (AR) was noted in 16 (21.3 %) patients at discharge while 8 of them resolved during follow-up. Multivariable analysis revealed that procedure-induced AR was associated device diameter to patients’ weight (OR = 12.3 95 % CI 1.5- 99.2). Perventricular device closure was failed in 11 patients, preoperative aortic valve prolapse was the major risk factor for failure of the procedure (OR = 65 95 % CI 7.5- 564.1). CONCLUSION: Perventricular closure of doubly committed subarterial VSDs appears to be a safe and effective minimally invasive treatment option in selected patients with good long-term outcomes. CLINICAL TRIAL REGISTRATION: Unique Identifier: ChiCTR-TNC-00000203. BioMed Central 2015-09-15 /pmc/articles/PMC4572622/ /pubmed/26374555 http://dx.doi.org/10.1186/s13019-015-0326-6 Text en © Zhang et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Zhang, Shu
Zhu, Da
An, Qi
Tang, Hong
Li, Dajiang
Lin, Ke
Minimally invasive perventricular device closure of doubly committed sub-arterial ventricular septal defects: single center long-term follow-up results
title Minimally invasive perventricular device closure of doubly committed sub-arterial ventricular septal defects: single center long-term follow-up results
title_full Minimally invasive perventricular device closure of doubly committed sub-arterial ventricular septal defects: single center long-term follow-up results
title_fullStr Minimally invasive perventricular device closure of doubly committed sub-arterial ventricular septal defects: single center long-term follow-up results
title_full_unstemmed Minimally invasive perventricular device closure of doubly committed sub-arterial ventricular septal defects: single center long-term follow-up results
title_short Minimally invasive perventricular device closure of doubly committed sub-arterial ventricular septal defects: single center long-term follow-up results
title_sort minimally invasive perventricular device closure of doubly committed sub-arterial ventricular septal defects: single center long-term follow-up results
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4572622/
https://www.ncbi.nlm.nih.gov/pubmed/26374555
http://dx.doi.org/10.1186/s13019-015-0326-6
work_keys_str_mv AT zhangshu minimallyinvasiveperventriculardeviceclosureofdoublycommittedsubarterialventricularseptaldefectssinglecenterlongtermfollowupresults
AT zhuda minimallyinvasiveperventriculardeviceclosureofdoublycommittedsubarterialventricularseptaldefectssinglecenterlongtermfollowupresults
AT anqi minimallyinvasiveperventriculardeviceclosureofdoublycommittedsubarterialventricularseptaldefectssinglecenterlongtermfollowupresults
AT tanghong minimallyinvasiveperventriculardeviceclosureofdoublycommittedsubarterialventricularseptaldefectssinglecenterlongtermfollowupresults
AT lidajiang minimallyinvasiveperventriculardeviceclosureofdoublycommittedsubarterialventricularseptaldefectssinglecenterlongtermfollowupresults
AT linke minimallyinvasiveperventriculardeviceclosureofdoublycommittedsubarterialventricularseptaldefectssinglecenterlongtermfollowupresults